• A T Dennis and J M Castro.
• Department of Anaesthesia, The Royal Women's Hospital, Parkville, Victoria, Australia; Department of Pharmacology and Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia. Electronic address: alicia.dennis@thewomens.org.au.
• Int J Obstet Anesth. 2014 Aug 1;23(3):260-6.

AbstractPeripartum heart failure due to preeclampsia or peripartum cardiomyopathy represents a significant global health issue. Transthoracic echocardiography enables differentiation of heart failure with preserved ejection fraction, commonly observed in women with preeclampsia, from that with peripartum cardiomyopathy in which a reduced ejection fraction is more common. An understanding of the different definitions and diagnostic features of these two diseases, as well as accurate characterisation of the haemodynamics in preeclampsia and peripartum cardiomyopathy, allows clinicians to manage these conditions appropriately. This article outlines the echocardiographic differences between preeclampsia and peripartum cardiomyopathy, the likely mechanisms for heart failure in preeclampsia and the relevance of these differences to clinicians in relation to prevention and treatment. It also emphasises the importance of disease definitions as a key framework for the more consistent classification of the two diseases.Copyright © 2014 Elsevier Ltd. All rights reserved.

21 keywords...

hide…